Ignite Creation Date:
2025-12-25 @ 3:09 AM
Ignite Modification Date:
2026-01-08 @ 7:24 AM
Study NCT ID:
NCT00473005
Status:
TERMINATED
Last Update Posted:
2012-05-28
First Post:
2007-05-11
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase I Oral mTOR Inhibitor RAD001 in Combo w/ Capecitabine for Metastatic Breast
Sponsor:
Stanford University
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
BRSMTS0010
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
Dr. Ellie Guardino MD/PhD
Old Organization:
Stanford University School of Medicine
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | INDUSTRY | View |